Kaneka (4118) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
31 Aug, 2026Executive summary
Achieved record high net sales of ¥811.6 billion (up 0.5% YoY) and record high net income of ¥31.0 billion (up 22.4% YoY).
Operating income declined 17.9% YoY to ¥32.9 billion, and ordinary income fell 12.1% to ¥28.9 billion.
Comprehensive income surged 64.7% to ¥50.8 billion.
Further reduction of cross-shareholdings, with disposal totaling ¥22.7 billion in FY2025.
Financial highlights
Net sales: ¥811.6 billion (YoY +0.5%), operating income: ¥32.9 billion (YoY -17.9%), net income: ¥31.0 billion (YoY +22.4%).
Gross profit was ¥225.6 billion, nearly flat YoY.
Net income per share: ¥501.26; annual dividend: ¥160 per share (YoY +¥30).
Equity ratio: 52.0%; debt equity ratio: 0.42.
Cash and cash equivalents at year-end: ¥48.9 billion.
Outlook and guidance
FY2026 forecast: net sales ¥820.0 billion (+1.0% YoY), operating income ¥36.0 billion (+9.4% YoY), net income ¥31.5 billion (+1.7% YoY), annual dividend ¥210 per share.
Will actively invest in Life Science and Leading-edge businesses to accelerate growth.
Cautious outlook due to potential demand adjustments and profit margin fluctuations from Middle East situation.
Latest events from Kaneka
- Strong sales and profit growth across all segments, with robust outlook and higher dividends.4118
Q1 2025 - Operating income surged 51.5% year-over-year, led by strong growth in core segments.4118
Q2 2025 - Record sales and profits led to upward revisions in earnings and dividend forecasts.4118
Q3 2025 - Record sales and profit growth, with further gains, higher dividends, and share buyback planned.4118
Q4 2025 - Profits fell despite higher sales, but a rebound is expected as market conditions improve.4118
Q1 2026 - Operating income fell despite higher sales, but recovery is expected in 2H.4118
Q2 2026 - Net income rose despite flat sales, driven by Health Care, Nutrition, and innovation.4118
Q3 2026 - Record-high sales and profits across all segments, with robust outlook amid global volatility.4118
Q1 2027